Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.34093818 |
2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.34093818 |
3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.28616976 |
4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.28616976 |
5 | modulation by symbiont of host immune response (GO:0052553) | 4.28616976 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.28616976 |
7 | modulation by symbiont of host defense response (GO:0052031) | 4.28616976 |
8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.28616976 |
9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.25976275 |
10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.95983957 |
11 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.94760856 |
12 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.80527572 |
13 | ribosomal small subunit assembly (GO:0000028) | 3.76896119 |
14 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.76763026 |
15 | detection of other organism (GO:0098543) | 3.76135894 |
16 | detection of bacterium (GO:0016045) | 3.69331557 |
17 | cellular response to zinc ion (GO:0071294) | 3.66120821 |
18 | sarcomere organization (GO:0045214) | 3.65869318 |
19 | DNA deamination (GO:0045006) | 3.65572490 |
20 | regulation of mast cell degranulation (GO:0043304) | 3.64764383 |
21 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.63820700 |
22 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.63577813 |
23 | muscle filament sliding (GO:0030049) | 3.63328086 |
24 | actin-myosin filament sliding (GO:0033275) | 3.63328086 |
25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.60964141 |
26 | macrophage activation involved in immune response (GO:0002281) | 3.57037064 |
27 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.45893053 |
28 | leukocyte aggregation (GO:0070486) | 3.41520536 |
29 | regulation of leukocyte degranulation (GO:0043300) | 3.36517001 |
30 | IMP metabolic process (GO:0046040) | 3.36437984 |
31 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.34242685 |
32 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.31515635 |
33 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.21557807 |
34 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.19946792 |
35 | viral transcription (GO:0019083) | 3.17751297 |
36 | regulation of gamma-delta T cell activation (GO:0046643) | 3.16655302 |
37 | immunoglobulin mediated immune response (GO:0016064) | 3.15180051 |
38 | positive thymic T cell selection (GO:0045059) | 3.15008581 |
39 | detection of external biotic stimulus (GO:0098581) | 3.14849094 |
40 | IMP biosynthetic process (GO:0006188) | 3.14256571 |
41 | DNA strand elongation (GO:0022616) | 3.12664912 |
42 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.11143404 |
43 | protein localization to endosome (GO:0036010) | 3.09961464 |
44 | granulocyte activation (GO:0036230) | 3.09183785 |
45 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.08976153 |
46 | neutrophil activation (GO:0042119) | 3.07801272 |
47 | DNA unwinding involved in DNA replication (GO:0006268) | 3.07351185 |
48 | positive regulation of B cell differentiation (GO:0045579) | 3.06687769 |
49 | regulation of superoxide anion generation (GO:0032928) | 3.04904434 |
50 | translational termination (GO:0006415) | 3.03271469 |
51 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.98791397 |
52 | positive regulation of mast cell activation (GO:0033005) | 2.98088541 |
53 | negative regulation of phagocytosis (GO:0050765) | 2.97314854 |
54 | regulation of T cell tolerance induction (GO:0002664) | 2.93964116 |
55 | myeloid cell activation involved in immune response (GO:0002275) | 2.93750121 |
56 | amino sugar catabolic process (GO:0046348) | 2.91246958 |
57 | DNA replication initiation (GO:0006270) | 2.91035825 |
58 | translational elongation (GO:0006414) | 2.90581966 |
59 | regulation of B cell differentiation (GO:0045577) | 2.88437646 |
60 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.86702985 |
61 | response to host immune response (GO:0052572) | 2.86702985 |
62 | negative regulation of cell killing (GO:0031342) | 2.85878616 |
63 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.85878616 |
64 | B cell mediated immunity (GO:0019724) | 2.85731941 |
65 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.84389916 |
66 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.83096120 |
67 | positive regulation of mast cell degranulation (GO:0043306) | 2.83096120 |
68 | detection of biotic stimulus (GO:0009595) | 2.81518405 |
69 | glycosphingolipid catabolic process (GO:0046479) | 2.79724134 |
70 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.77610103 |
71 | response to muramyl dipeptide (GO:0032495) | 2.74661576 |
72 | positive regulation of leukocyte degranulation (GO:0043302) | 2.74429463 |
73 | myeloid dendritic cell differentiation (GO:0043011) | 2.74192286 |
74 | detection of molecule of bacterial origin (GO:0032490) | 2.73639393 |
75 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.73064222 |
76 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.72857674 |
77 | response to host (GO:0075136) | 2.72857674 |
78 | response to host defenses (GO:0052200) | 2.72857674 |
79 | B cell receptor signaling pathway (GO:0050853) | 2.72476820 |
80 | heart contraction (GO:0060047) | 2.71817538 |
81 | heart process (GO:0003015) | 2.71817538 |
82 | actin nucleation (GO:0045010) | 2.69567084 |
83 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.68728916 |
84 | telomere maintenance via recombination (GO:0000722) | 2.68640187 |
85 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.67614632 |
86 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.67505757 |
87 | regulation of relaxation of muscle (GO:1901077) | 2.67310389 |
88 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.65995204 |
89 | tricarboxylic acid cycle (GO:0006099) | 2.65556493 |
90 | T cell migration (GO:0072678) | 2.65230485 |
91 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.64920330 |
92 | regulation of regulated secretory pathway (GO:1903305) | 2.64906735 |
93 | myeloid dendritic cell activation (GO:0001773) | 2.64507326 |
94 | germinal center formation (GO:0002467) | 2.64274110 |
95 | regulation of defense response to virus by virus (GO:0050690) | 2.64035825 |
96 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.64009952 |
97 | regulation of mast cell activation (GO:0033003) | 2.63807045 |
98 | regulation of tolerance induction (GO:0002643) | 2.63183968 |
99 | negative thymic T cell selection (GO:0045060) | 2.62746926 |
100 | * barbed-end actin filament capping (GO:0051016) | 2.62587850 |
101 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.62249873 |
102 | formation of translation preinitiation complex (GO:0001731) | 2.61681271 |
103 | pinocytosis (GO:0006907) | 2.60567111 |
104 | negative T cell selection (GO:0043383) | 2.60203421 |
105 | respiratory burst (GO:0045730) | 2.58918991 |
106 | mannose metabolic process (GO:0006013) | 2.58862333 |
107 | type I interferon signaling pathway (GO:0060337) | 2.58700900 |
108 | cellular response to type I interferon (GO:0071357) | 2.58700900 |
109 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.58632371 |
110 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.58412115 |
111 | regulation of response to interferon-gamma (GO:0060330) | 2.58370902 |
112 | cardiac myofibril assembly (GO:0055003) | 2.57483742 |
113 | negative regulation of innate immune response (GO:0045824) | 2.56753891 |
114 | myofibril assembly (GO:0030239) | 2.56664371 |
115 | regulation of antigen processing and presentation (GO:0002577) | 2.55786566 |
116 | actin-mediated cell contraction (GO:0070252) | 2.55615820 |
117 | thymic T cell selection (GO:0045061) | 2.54502044 |
118 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.54278197 |
119 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.53264892 |
120 | response to type I interferon (GO:0034340) | 2.52624284 |
121 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.51975842 |
122 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.51509124 |
123 | cellular response to interferon-beta (GO:0035458) | 2.51247650 |
124 | interferon-gamma production (GO:0032609) | 2.50893141 |
125 | * positive regulation of lamellipodium assembly (GO:0010592) | 2.50770531 |
126 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.49966036 |
127 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.49884209 |
128 | positive regulation of antigen processing and presentation (GO:0002579) | 2.49222965 |
129 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.48748968 |
130 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.48226684 |
131 | translational initiation (GO:0006413) | 2.47869020 |
132 | response to interleukin-15 (GO:0070672) | 2.46957190 |
133 | glycolipid catabolic process (GO:0019377) | 2.46710966 |
134 | macrophage activation (GO:0042116) | 2.45597632 |
135 | morphogenesis of an endothelium (GO:0003159) | 2.45320353 |
136 | endothelial tube morphogenesis (GO:0061154) | 2.45320353 |
137 | regulation of skeletal muscle contraction (GO:0014819) | 2.44686191 |
138 | regulation of necrotic cell death (GO:0010939) | 2.43966194 |
139 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.43647679 |
140 | oxidative phosphorylation (GO:0006119) | 2.40583251 |
141 | maturation of SSU-rRNA (GO:0030490) | 2.40520731 |
142 | protein targeting to ER (GO:0045047) | 2.39590092 |
143 | ribosomal small subunit biogenesis (GO:0042274) | 2.39583332 |
144 | regulation of necroptotic process (GO:0060544) | 2.39545382 |
145 | mitotic recombination (GO:0006312) | 2.38278681 |
146 | cotranslational protein targeting to membrane (GO:0006613) | 2.38121017 |
147 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.35566437 |
148 | viral life cycle (GO:0019058) | 2.34476741 |
149 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.34219589 |
150 | mast cell activation (GO:0045576) | 2.31662087 |
151 | telomere maintenance via telomere lengthening (GO:0010833) | 2.31338441 |
152 | cellular protein complex disassembly (GO:0043624) | 2.30900443 |
153 | T cell apoptotic process (GO:0070231) | 2.30601324 |
154 | positive T cell selection (GO:0043368) | 2.30402539 |
155 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.29880812 |
156 | NIK/NF-kappaB signaling (GO:0038061) | 2.29435879 |
157 | response to interferon-beta (GO:0035456) | 2.28750314 |
158 | cellular extravasation (GO:0045123) | 2.28684628 |
159 | DNA replication checkpoint (GO:0000076) | 2.27976205 |
160 | skeletal muscle contraction (GO:0003009) | 2.24059888 |
161 | response to peptidoglycan (GO:0032494) | 2.23524686 |
162 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.23356478 |
163 | negative regulation of necroptotic process (GO:0060546) | 2.23246415 |
164 | negative regulation of interleukin-12 production (GO:0032695) | 2.22329977 |
165 | protein localization to endoplasmic reticulum (GO:0070972) | 2.21661429 |
166 | neutrophil activation involved in immune response (GO:0002283) | 2.21180745 |
167 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.20897960 |
168 | T cell homeostasis (GO:0043029) | 2.20606712 |
169 | protein localization to kinetochore (GO:0034501) | 2.19983129 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.74925968 |
2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.44758014 |
3 | MYC_22102868_ChIP-Seq_BL_Human | 2.85053005 |
4 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.56891560 |
5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.52865181 |
6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.48191373 |
7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.40034501 |
8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.38586631 |
9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.36356074 |
10 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.34871348 |
11 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.29838546 |
12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.29731916 |
13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.27959045 |
14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.22778178 |
15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.22130157 |
16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.18132871 |
17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.07120915 |
18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.05150900 |
19 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04191851 |
20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.02500627 |
21 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97978471 |
22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.97789664 |
23 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.95340221 |
24 | * MAF_26560356_Chip-Seq_TH1_Human | 1.94260701 |
25 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.92289945 |
26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.86731191 |
27 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.82626234 |
28 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.82058336 |
29 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.80516256 |
30 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.78586885 |
31 | UTX_26944678_Chip-Seq_JUKART_Human | 1.75284179 |
32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.74864769 |
33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.73541342 |
34 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.71372828 |
35 | MYB_26560356_Chip-Seq_TH2_Human | 1.69976163 |
36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.68373641 |
37 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67941933 |
38 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.67002448 |
39 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.66986243 |
40 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.65464571 |
41 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.63610804 |
42 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.61743107 |
43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59041234 |
44 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.58991368 |
45 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.58479839 |
46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58225872 |
47 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.57854571 |
48 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55854201 |
49 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.55540774 |
50 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.53263334 |
51 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.53110467 |
52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.51973992 |
53 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49920860 |
54 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.49361667 |
55 | MYB_26560356_Chip-Seq_TH1_Human | 1.46036406 |
56 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.45736129 |
57 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.45235764 |
58 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.44273857 |
59 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.42924689 |
60 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.42235570 |
61 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.41912285 |
62 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.40468299 |
63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39609105 |
64 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.38398138 |
65 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38071558 |
66 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.37927867 |
67 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.37843149 |
68 | SPI1_23127762_ChIP-Seq_K562_Human | 1.37512411 |
69 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.36569826 |
70 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.36230665 |
71 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.35181562 |
72 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35015909 |
73 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.35002091 |
74 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34697891 |
75 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.34054095 |
76 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.33824992 |
77 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.33723373 |
78 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33573963 |
79 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.32774393 |
80 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.31374679 |
81 | * MAF_26560356_Chip-Seq_TH2_Human | 1.31216373 |
82 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.30731533 |
83 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.30247836 |
84 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.29725541 |
85 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.28484313 |
86 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.28479565 |
87 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.28475485 |
88 | P68_20966046_ChIP-Seq_HELA_Human | 1.27569896 |
89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.25960595 |
90 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.25107776 |
91 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.24564667 |
92 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23260693 |
93 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.22991091 |
94 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.22940556 |
95 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.22171765 |
96 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21658836 |
97 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21082298 |
98 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.20469171 |
99 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.20460311 |
100 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.20323914 |
101 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.18957087 |
102 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.17704597 |
103 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17195607 |
104 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.16458515 |
105 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.15724122 |
106 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15163757 |
107 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.15080591 |
108 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.14377227 |
109 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.13817510 |
110 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.13043465 |
111 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.12410363 |
112 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.12218912 |
113 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.11943420 |
114 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11042159 |
115 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10930135 |
116 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.10598364 |
117 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.10359985 |
118 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.10357865 |
119 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.10349383 |
120 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09999483 |
121 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09291972 |
122 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.09281066 |
123 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.09177580 |
124 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.06835189 |
125 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.06677143 |
126 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.05788548 |
127 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.05475373 |
128 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.04632629 |
129 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.04468192 |
130 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.03606388 |
131 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03363845 |
132 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.03029548 |
133 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.02420424 |
134 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.01890355 |
135 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01241403 |
136 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.01130752 |
137 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.99957704 |
138 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.99750598 |
139 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.99304949 |
140 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98698563 |
141 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98238943 |
142 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96931062 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003646_muscle_fatigue | 3.54155091 |
2 | MP0001835_abnormal_antigen_presentation | 2.98009484 |
3 | MP0002837_dystrophic_cardiac_calcinosis | 2.85536046 |
4 | MP0005451_abnormal_body_composition | 2.78617050 |
5 | MP0002396_abnormal_hematopoietic_system | 2.59022053 |
6 | MP0004084_abnormal_cardiac_muscle | 2.57408769 |
7 | MP0003763_abnormal_thymus_physiology | 2.50897779 |
8 | MP0000751_myopathy | 2.44426241 |
9 | MP0009840_abnormal_foam_cell | 2.43017244 |
10 | MP0005671_abnormal_response_to | 2.40404881 |
11 | MP0008260_abnormal_autophagy | 2.35324578 |
12 | MP0000685_abnormal_immune_system | 2.32319707 |
13 | MP0003436_decreased_susceptibility_to | 2.23416972 |
14 | MP0009785_altered_susceptibility_to | 2.21616788 |
15 | MP0003303_peritoneal_inflammation | 2.18594368 |
16 | MP0000749_muscle_degeneration | 2.16849241 |
17 | MP0001800_abnormal_humoral_immune | 2.05291652 |
18 | MP0002398_abnormal_bone_marrow | 1.97253306 |
19 | MP0002420_abnormal_adaptive_immunity | 1.97076170 |
20 | MP0001819_abnormal_immune_cell | 1.95654056 |
21 | MP0005000_abnormal_immune_tolerance | 1.94206901 |
22 | MP0003693_abnormal_embryo_hatching | 1.93334887 |
23 | MP0002452_abnormal_antigen_presenting | 1.92723065 |
24 | MP0005025_abnormal_response_to | 1.92409609 |
25 | MP0004036_abnormal_muscle_relaxation | 1.89875832 |
26 | MP0001853_heart_inflammation | 1.84077395 |
27 | MP0003075_altered_response_to | 1.83809663 |
28 | MP0004510_myositis | 1.82685606 |
29 | MP0005330_cardiomyopathy | 1.81845714 |
30 | MP0002723_abnormal_immune_serum | 1.81416101 |
31 | MP0003806_abnormal_nucleotide_metabolis | 1.80561260 |
32 | MP0009333_abnormal_splenocyte_physiolog | 1.79823256 |
33 | MP0002419_abnormal_innate_immunity | 1.77602734 |
34 | MP0000343_altered_response_to | 1.77053345 |
35 | MP0000750_abnormal_muscle_regeneration | 1.76105244 |
36 | MP0004087_abnormal_muscle_fiber | 1.73541448 |
37 | MP0002148_abnormal_hypersensitivity_rea | 1.73483578 |
38 | MP0004215_abnormal_myocardial_fiber | 1.72393165 |
39 | MP0005387_immune_system_phenotype | 1.72329851 |
40 | MP0001790_abnormal_immune_system | 1.72329851 |
41 | MP0004808_abnormal_hematopoietic_stem | 1.70426977 |
42 | MP0000716_abnormal_immune_system | 1.69650679 |
43 | MP0003828_pulmonary_edema | 1.67891801 |
44 | MP0002722_abnormal_immune_system | 1.65991556 |
45 | MP0000689_abnormal_spleen_morphology | 1.65506611 |
46 | MP0003077_abnormal_cell_cycle | 1.65309207 |
47 | MP0002106_abnormal_muscle_physiology | 1.65155878 |
48 | MP0002405_respiratory_system_inflammati | 1.62620820 |
49 | MP0003221_abnormal_cardiomyocyte_apopto | 1.61519021 |
50 | MP0010094_abnormal_chromosome_stability | 1.58812346 |
51 | MP0004957_abnormal_blastocyst_morpholog | 1.54595262 |
52 | MP0002429_abnormal_blood_cell | 1.53797921 |
53 | MP0000703_abnormal_thymus_morphology | 1.53462890 |
54 | MP0002998_abnormal_bone_remodeling | 1.51588532 |
55 | MP0005464_abnormal_platelet_physiology | 1.48994349 |
56 | MP0002269_muscular_atrophy | 1.48965880 |
57 | MP0000604_amyloidosis | 1.48009421 |
58 | MP0003705_abnormal_hypodermis_morpholog | 1.47996479 |
59 | MP0010630_abnormal_cardiac_muscle | 1.47907764 |
60 | MP0002166_altered_tumor_susceptibility | 1.46127932 |
61 | MP0001545_abnormal_hematopoietic_system | 1.43898740 |
62 | MP0005397_hematopoietic_system_phenotyp | 1.43898740 |
63 | MP0009278_abnormal_bone_marrow | 1.42999225 |
64 | MP0010352_gastrointestinal_tract_polyps | 1.40418157 |
65 | MP0000490_abnormal_crypts_of | 1.40241380 |
66 | MP0003111_abnormal_nucleus_morphology | 1.39467214 |
67 | MP0004145_abnormal_muscle_electrophysio | 1.38189507 |
68 | MP0004130_abnormal_muscle_cell | 1.33447041 |
69 | MP0001544_abnormal_cardiovascular_syste | 1.33066150 |
70 | MP0005385_cardiovascular_system_phenoty | 1.33066150 |
71 | MP0006036_abnormal_mitochondrial_physio | 1.33030607 |
72 | MP0010155_abnormal_intestine_physiology | 1.32163994 |
73 | MP0003279_aneurysm | 1.31821720 |
74 | MP0001873_stomach_inflammation | 1.31353314 |
75 | MP0000759_abnormal_skeletal_muscle | 1.31038989 |
76 | MP0000747_muscle_weakness | 1.29415293 |
77 | MP0009764_decreased_sensitivity_to | 1.27499824 |
78 | MP0000858_altered_metastatic_potential | 1.26651374 |
79 | MP0000465_gastrointestinal_hemorrhage | 1.25694374 |
80 | MP0005166_decreased_susceptibility_to | 1.25176068 |
81 | MP0002972_abnormal_cardiac_muscle | 1.22031914 |
82 | MP0002877_abnormal_melanocyte_morpholog | 1.21925509 |
83 | MP0008057_abnormal_DNA_replication | 1.20214950 |
84 | MP0001845_abnormal_inflammatory_respons | 1.15899163 |
85 | MP0002006_tumorigenesis | 1.13740402 |
86 | MP0006082_CNS_inflammation | 1.12637922 |
87 | MP0002019_abnormal_tumor_incidence | 1.12497236 |
88 | MP0005369_muscle_phenotype | 1.11668223 |
89 | MP0003566_abnormal_cell_adhesion | 1.09582457 |
90 | MP0005620_abnormal_muscle_contractility | 1.04155997 |
91 | MP0008058_abnormal_DNA_repair | 1.03627669 |
92 | MP0005058_abnormal_lysosome_morphology | 1.02682949 |
93 | MP0008007_abnormal_cellular_replicative | 1.01966129 |
94 | MP0008004_abnormal_stomach_pH | 1.01759505 |
95 | MP0003724_increased_susceptibility_to | 1.01295457 |
96 | MP0004484_altered_response_of | 1.01006548 |
97 | MP0001849_ear_inflammation | 0.99569777 |
98 | MP0008775_abnormal_heart_ventricle | 0.98787661 |
99 | MP0003567_abnormal_fetal_cardiomyocyte | 0.98667236 |
100 | MP0003448_altered_tumor_morphology | 0.98133266 |
101 | MP0005165_increased_susceptibility_to | 0.96150494 |
102 | MP0005390_skeleton_phenotype | 0.96080646 |
103 | MP0003866_abnormal_defecation | 0.95928371 |
104 | MP0008438_abnormal_cutaneous_collagen | 0.95367143 |
105 | MP0003183_abnormal_peptide_metabolism | 0.95056441 |
106 | MP0001851_eye_inflammation | 0.94531859 |
107 | MP0002132_abnormal_respiratory_system | 0.94120520 |
108 | MP0010307_abnormal_tumor_latency | 0.92499817 |
109 | MP0003172_abnormal_lysosome_physiology | 0.92441959 |
110 | MP0001533_abnormal_skeleton_physiology | 0.92360635 |
111 | MP0003329_amyloid_beta_deposits | 0.92227925 |
112 | MP0003300_gastrointestinal_ulcer | 0.92102333 |
113 | MP0003191_abnormal_cellular_cholesterol | 0.90742473 |
114 | MP0003453_abnormal_keratinocyte_physiol | 0.90684124 |
115 | MP0003091_abnormal_cell_migration | 0.89693259 |
116 | MP0006054_spinal_hemorrhage | 0.89322510 |
117 | MP0005310_abnormal_salivary_gland | 0.89037692 |
118 | MP0008469_abnormal_protein_level | 0.87981145 |
119 | MP0004947_skin_inflammation | 0.87468374 |
120 | MP0004858_abnormal_nervous_system | 0.86317394 |
121 | MP0001730_embryonic_growth_arrest | 0.86242702 |
122 | MP0009763_increased_sensitivity_to | 0.86111941 |
123 | MP0000313_abnormal_cell_death | 0.85581873 |
124 | MP0000350_abnormal_cell_proliferation | 0.84597605 |
125 | MP0003795_abnormal_bone_structure | 0.82889542 |
126 | MP0000249_abnormal_blood_vessel | 0.82876203 |
127 | MP0008874_decreased_physiological_sensi | 0.81011931 |
128 | MP0004233_abnormal_muscle_weight | 0.80786507 |
129 | MP0005023_abnormal_wound_healing | 0.80750240 |
130 | MP0002332_abnormal_exercise_endurance | 0.80170696 |
131 | MP0001958_emphysema | 0.77462420 |
132 | MP0005164_abnormal_response_to | 0.77058839 |
133 | MP0002933_joint_inflammation | 0.76567879 |
134 | MP0003656_abnormal_erythrocyte_physiolo | 0.75237948 |
135 | MP0004185_abnormal_adipocyte_glucose | 0.74749744 |
136 | MP0004883_abnormal_blood_vessel | 0.74270191 |
137 | MP0001542_abnormal_bone_strength | 0.73825583 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Exercise-induced muscle cramps (HP:0003710) | 4.29746800 |
2 | Abnormality of glycolipid metabolism (HP:0010969) | 4.29631422 |
3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.29631422 |
4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.29631422 |
5 | Recurrent abscess formation (HP:0002722) | 4.04635451 |
6 | Muscle fiber inclusion bodies (HP:0100299) | 3.98316736 |
7 | Ventricular tachycardia (HP:0004756) | 3.93527015 |
8 | Exercise-induced myalgia (HP:0003738) | 3.86078600 |
9 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.78133983 |
10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.74542394 |
11 | Eczematoid dermatitis (HP:0000976) | 3.69851531 |
12 | Calf muscle hypertrophy (HP:0008981) | 3.59683976 |
13 | Sudden death (HP:0001699) | 3.51917168 |
14 | Nemaline bodies (HP:0003798) | 3.50552897 |
15 | IgM deficiency (HP:0002850) | 3.49739682 |
16 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.39601595 |
17 | Myoglobinuria (HP:0002913) | 3.38992321 |
18 | Rhabdomyolysis (HP:0003201) | 3.24529100 |
19 | Subaortic stenosis (HP:0001682) | 3.21499473 |
20 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.21499473 |
21 | Asymmetric septal hypertrophy (HP:0001670) | 3.14935626 |
22 | Muscle fiber splitting (HP:0003555) | 3.09223091 |
23 | Purpura (HP:0000979) | 3.08530091 |
24 | Thrombocytosis (HP:0001894) | 3.05031269 |
25 | Recurrent bacterial skin infections (HP:0005406) | 3.03793263 |
26 | Vacuolated lymphocytes (HP:0001922) | 3.03702490 |
27 | Dysostosis multiplex (HP:0000943) | 3.03694502 |
28 | Myositis (HP:0100614) | 2.94908734 |
29 | Systemic lupus erythematosus (HP:0002725) | 2.86152813 |
30 | Recurrent fungal infections (HP:0002841) | 2.85609135 |
31 | Loss of speech (HP:0002371) | 2.84564133 |
32 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.82215580 |
33 | EMG: myopathic abnormalities (HP:0003458) | 2.79026976 |
34 | Recurrent viral infections (HP:0004429) | 2.78572923 |
35 | Chronic otitis media (HP:0000389) | 2.74583195 |
36 | Lipoatrophy (HP:0100578) | 2.74516272 |
37 | Orchitis (HP:0100796) | 2.71064097 |
38 | Ulnar deviation of the wrist (HP:0003049) | 2.65091163 |
39 | Amyloidosis (HP:0011034) | 2.65039140 |
40 | Hepatosplenomegaly (HP:0001433) | 2.64949016 |
41 | Progressive muscle weakness (HP:0003323) | 2.57709247 |
42 | Abnormality of the nasal mucosa (HP:0000433) | 2.57663221 |
43 | Vertebral compression fractures (HP:0002953) | 2.57497495 |
44 | Spontaneous hematomas (HP:0007420) | 2.56685940 |
45 | Type 1 muscle fiber predominance (HP:0003803) | 2.56202548 |
46 | Abnormality of T cells (HP:0002843) | 2.53552653 |
47 | Recurrent bronchitis (HP:0002837) | 2.52061773 |
48 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.50251924 |
49 | Abnormality of T cell physiology (HP:0011840) | 2.50017805 |
50 | Prolonged bleeding time (HP:0003010) | 2.49945250 |
51 | Difficulty running (HP:0009046) | 2.49412069 |
52 | Increased serum ferritin (HP:0003281) | 2.49340786 |
53 | Epistaxis (HP:0000421) | 2.47051913 |
54 | Obstructive lung disease (HP:0006536) | 2.46034047 |
55 | Chronic obstructive pulmonary disease (HP:0006510) | 2.46034047 |
56 | Upper motor neuron abnormality (HP:0002127) | 2.44431525 |
57 | Panhypogammaglobulinemia (HP:0003139) | 2.44202636 |
58 | Myopathic facies (HP:0002058) | 2.43389095 |
59 | Hyporeflexia of lower limbs (HP:0002600) | 2.42774669 |
60 | Increased connective tissue (HP:0009025) | 2.42195102 |
61 | Frequent falls (HP:0002359) | 2.41940568 |
62 | Axonal loss (HP:0003447) | 2.41364476 |
63 | Abnormality of the calf musculature (HP:0001430) | 2.40400852 |
64 | Gingivitis (HP:0000230) | 2.39322420 |
65 | Areflexia of lower limbs (HP:0002522) | 2.37476314 |
66 | Urticaria (HP:0001025) | 2.37086532 |
67 | Agnosia (HP:0010524) | 2.36769733 |
68 | Multiple enchondromatosis (HP:0005701) | 2.36580603 |
69 | Supraventricular tachycardia (HP:0004755) | 2.36420595 |
70 | Chest pain (HP:0100749) | 2.35459805 |
71 | Cellulitis (HP:0100658) | 2.35135968 |
72 | Mediastinal lymphadenopathy (HP:0100721) | 2.34865129 |
73 | Nasal polyposis (HP:0100582) | 2.34672068 |
74 | Atrial fibrillation (HP:0005110) | 2.33802445 |
75 | Supraventricular arrhythmia (HP:0005115) | 2.30265683 |
76 | Gastrointestinal inflammation (HP:0004386) | 2.29266339 |
77 | Distal arthrogryposis (HP:0005684) | 2.27653956 |
78 | Meningitis (HP:0001287) | 2.26182747 |
79 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.24682690 |
80 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.24682690 |
81 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.24682690 |
82 | Myocardial infarction (HP:0001658) | 2.24056559 |
83 | Primary atrial arrhythmia (HP:0001692) | 2.23945457 |
84 | Dilated cardiomyopathy (HP:0001644) | 2.23642582 |
85 | Abnormality of macrophages (HP:0004311) | 2.23547317 |
86 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.22529203 |
87 | Pustule (HP:0200039) | 2.21004252 |
88 | Inflammation of the large intestine (HP:0002037) | 2.20887332 |
89 | Gastrointestinal infarctions (HP:0005244) | 2.18792345 |
90 | Difficulty climbing stairs (HP:0003551) | 2.17905086 |
91 | Hypertensive crisis (HP:0100735) | 2.17071353 |
92 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.16566504 |
93 | Bundle branch block (HP:0011710) | 2.16406880 |
94 | Myotonia (HP:0002486) | 2.14551521 |
95 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.14441518 |
96 | Facial diplegia (HP:0001349) | 2.14043929 |
97 | Abnormal number of erythroid precursors (HP:0012131) | 2.14041978 |
98 | Distal lower limb amyotrophy (HP:0008944) | 2.13513075 |
99 | Increased IgM level (HP:0003496) | 2.12999230 |
100 | Retrobulbar optic neuritis (HP:0100654) | 2.11978447 |
101 | Optic neuritis (HP:0100653) | 2.11978447 |
102 | Recurrent cutaneous fungal infections (HP:0011370) | 2.11641112 |
103 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.11641112 |
104 | Palpitations (HP:0001962) | 2.09916596 |
105 | Ragged-red muscle fibers (HP:0003200) | 2.09358819 |
106 | Petechiae (HP:0000967) | 2.09152479 |
107 | Mucopolysacchariduria (HP:0008155) | 2.08711082 |
108 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.08711082 |
109 | Increased variability in muscle fiber diameter (HP:0003557) | 2.08156466 |
110 | T lymphocytopenia (HP:0005403) | 2.04859554 |
111 | Progressive neurologic deterioration (HP:0002344) | 2.04319190 |
112 | Bulbar palsy (HP:0001283) | 2.03544522 |
113 | Recurrent skin infections (HP:0001581) | 2.03396889 |
114 | Limb-girdle muscle atrophy (HP:0003797) | 2.03067297 |
115 | Disinhibition (HP:0000734) | 2.02860237 |
116 | Reticulocytopenia (HP:0001896) | 2.01805914 |
117 | Gingival bleeding (HP:0000225) | 2.01798070 |
118 | Vasculitis (HP:0002633) | 2.01712695 |
119 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.01386485 |
120 | Distal lower limb muscle weakness (HP:0009053) | 1.99856916 |
121 | Lymphopenia (HP:0001888) | 1.99790160 |
122 | Neck muscle weakness (HP:0000467) | 1.99167368 |
123 | Encephalitis (HP:0002383) | 1.98594455 |
124 | Muscle stiffness (HP:0003552) | 1.97107878 |
125 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.94891279 |
126 | Abnormality of T cell number (HP:0011839) | 1.94265095 |
127 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.94000250 |
128 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.94000250 |
129 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.92738915 |
130 | Abnormality of iron homeostasis (HP:0011031) | 1.92295686 |
131 | Achilles tendon contracture (HP:0001771) | 1.89328752 |
132 | Colitis (HP:0002583) | 1.87773088 |
133 | Abnormal platelet volume (HP:0011876) | 1.87081576 |
134 | Pulmonary infiltrates (HP:0002113) | 1.84260931 |
135 | Hypergammaglobulinemia (HP:0010702) | 1.83663642 |
136 | Abnormal platelet function (HP:0011869) | 1.81436130 |
137 | Impaired platelet aggregation (HP:0003540) | 1.81436130 |
138 | Increased IgE level (HP:0003212) | 1.81433183 |
139 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.80852888 |
140 | Hypertriglyceridemia (HP:0002155) | 1.80657194 |
141 | Polygenic inheritance (HP:0010982) | 1.80515045 |
142 | Episodic fever (HP:0001954) | 1.79315398 |
143 | Gastrointestinal stroma tumor (HP:0100723) | 1.79232616 |
144 | Birth length less than 3rd percentile (HP:0003561) | 1.78963345 |
145 | Amaurosis fugax (HP:0100576) | 1.78910668 |
146 | Fatigue (HP:0012378) | 1.78354673 |
147 | Stomatitis (HP:0010280) | 1.76999328 |
148 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.76551088 |
149 | Increased cerebral lipofuscin (HP:0011813) | 1.75809376 |
150 | Autoimmune thrombocytopenia (HP:0001973) | 1.75589822 |
151 | Calcaneovalgus deformity (HP:0001848) | 1.75240700 |
152 | Papilloma (HP:0012740) | 1.74839598 |
153 | Verrucae (HP:0200043) | 1.74839598 |
154 | Hepatic necrosis (HP:0002605) | 1.74630513 |
155 | Neuronal loss in central nervous system (HP:0002529) | 1.74541807 |
156 | Polycythemia (HP:0001901) | 1.73915862 |
157 | Eosinophilia (HP:0001880) | 1.72466258 |
158 | Neoplasm of head and neck (HP:0012288) | 1.72145198 |
159 | Abnormality of the Achilles tendon (HP:0005109) | 1.71445850 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 3.90098075 |
2 | TTN | 3.78391692 |
3 | PKN2 | 2.94716692 |
4 | PRPF4B | 2.81023634 |
5 | OBSCN | 2.46881195 |
6 | IRAK3 | 2.36149049 |
7 | TRIB3 | 2.34583609 |
8 | MAP2K3 | 2.15774384 |
9 | EEF2K | 2.15223886 |
10 | SMG1 | 2.09654012 |
11 | TYK2 | 2.08276003 |
12 | NME2 | 2.03514878 |
13 | FLT3 | 2.01829392 |
14 | TESK1 | 1.98046982 |
15 | ZAP70 | 1.90776085 |
16 | BLK | 1.89679108 |
17 | KIT | 1.89654145 |
18 | NEK1 | 1.88446348 |
19 | BTK | 1.84128529 |
20 | STK10 | 1.83219694 |
21 | IRAK4 | 1.82208428 |
22 | KDR | 1.78715782 |
23 | TXK | 1.73257981 |
24 | TESK2 | 1.61838020 |
25 | JAK3 | 1.60964601 |
26 | BUB1 | 1.59138617 |
27 | ERN1 | 1.57312872 |
28 | TBK1 | 1.53050752 |
29 | ARAF | 1.52410796 |
30 | WEE1 | 1.47748076 |
31 | MAP3K13 | 1.45131473 |
32 | MAP3K14 | 1.43765447 |
33 | TGFBR2 | 1.43066094 |
34 | MAP3K10 | 1.41218165 |
35 | TEC | 1.39958985 |
36 | CSF1R | 1.39639237 |
37 | MAPKAPK3 | 1.38364569 |
38 | BCKDK | 1.34781681 |
39 | ITK | 1.31176682 |
40 | GRK6 | 1.29288669 |
41 | LRRK2 | 1.28924591 |
42 | MAP3K11 | 1.22323481 |
43 | EPHB1 | 1.21572968 |
44 | FGR | 1.20057094 |
45 | ICK | 1.19219459 |
46 | PAK4 | 1.18151991 |
47 | LIMK1 | 1.18104812 |
48 | SYK | 1.14846094 |
49 | MAP3K1 | 1.13417757 |
50 | PHKG2 | 1.09173406 |
51 | PHKG1 | 1.09173406 |
52 | NEK2 | 1.08140931 |
53 | RPS6KA4 | 1.07928187 |
54 | IKBKE | 1.06993766 |
55 | TNK2 | 1.06439483 |
56 | SCYL2 | 1.06041896 |
57 | STK4 | 1.03360321 |
58 | MYLK | 1.02254243 |
59 | TGFBR1 | 1.01940721 |
60 | CDC7 | 1.01394704 |
61 | SIK1 | 1.01125967 |
62 | MOS | 1.00435436 |
63 | CLK1 | 0.99684253 |
64 | RPS6KB2 | 0.99035129 |
65 | DMPK | 0.97891096 |
66 | PDK3 | 0.94875921 |
67 | PDK4 | 0.94875921 |
68 | HCK | 0.94705174 |
69 | PIM1 | 0.92213449 |
70 | LCK | 0.89656101 |
71 | MUSK | 0.88594911 |
72 | PRKD2 | 0.88178082 |
73 | CDC42BPA | 0.85952684 |
74 | CDK4 | 0.85347335 |
75 | CSK | 0.83689916 |
76 | ILK | 0.82941436 |
77 | ABL2 | 0.80705687 |
78 | PIM2 | 0.80063387 |
79 | JAK1 | 0.79307249 |
80 | FES | 0.78714550 |
81 | MAP3K8 | 0.76621269 |
82 | SIK3 | 0.75323825 |
83 | TRPM7 | 0.73937214 |
84 | EIF2AK1 | 0.73144987 |
85 | PDPK1 | 0.72269724 |
86 | MAP3K6 | 0.71674221 |
87 | KSR2 | 0.71438954 |
88 | STK24 | 0.71404025 |
89 | MATK | 0.71163651 |
90 | PTK6 | 0.66569725 |
91 | PIK3CG | 0.65987079 |
92 | LYN | 0.65306550 |
93 | MARK2 | 0.65181642 |
94 | VRK2 | 0.64391633 |
95 | BMX | 0.62772566 |
96 | PRKG2 | 0.62723173 |
97 | IKBKB | 0.62257357 |
98 | FGFR4 | 0.61312925 |
99 | CAMKK2 | 0.60580854 |
100 | TIE1 | 0.60577914 |
101 | PDK1 | 0.57781193 |
102 | RIPK1 | 0.57363737 |
103 | RPS6KA6 | 0.56148241 |
104 | RIPK4 | 0.55324542 |
105 | TAOK1 | 0.54940332 |
106 | MAPK12 | 0.54723734 |
107 | MAP3K3 | 0.53980533 |
108 | TSSK6 | 0.53306740 |
109 | CDK7 | 0.52829328 |
110 | MAPK11 | 0.51871778 |
111 | CDK19 | 0.51590523 |
112 | RPS6KL1 | 0.51137128 |
113 | RPS6KC1 | 0.51137128 |
114 | TAOK2 | 0.50966759 |
115 | RPS6KA2 | 0.50782418 |
116 | ATR | 0.50670392 |
117 | DAPK3 | 0.50344505 |
118 | IRAK2 | 0.50046276 |
119 | PAK1 | 0.49079957 |
120 | BRAF | 0.49074032 |
121 | PDK2 | 0.48556462 |
122 | JAK2 | 0.48336008 |
123 | ALK | 0.48131774 |
124 | PASK | 0.47084193 |
125 | NLK | 0.47025621 |
126 | DAPK1 | 0.46153536 |
127 | ACVR1B | 0.46062411 |
128 | MAP2K6 | 0.44739370 |
129 | MARK3 | 0.43893998 |
130 | TLK1 | 0.43617828 |
131 | LMTK2 | 0.43547214 |
132 | CAMKK1 | 0.41962550 |
133 | MAPKAPK2 | 0.40900422 |
134 | MAP3K7 | 0.40479053 |
135 | DYRK1B | 0.40139477 |
136 | MAP3K5 | 0.40108368 |
137 | GRK7 | 0.39452740 |
138 | FGFR3 | 0.39021301 |
139 | MAPK4 | 0.39000436 |
140 | MAPK7 | 0.38126499 |
141 | FYN | 0.37545363 |
142 | VRK1 | 0.37530741 |
143 | RAF1 | 0.36859059 |
144 | HIPK2 | 0.34965108 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DNA replication_Homo sapiens_hsa03030 | 3.53155045 |
2 | Mismatch repair_Homo sapiens_hsa03430 | 2.63397627 |
3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.62745954 |
4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.50812817 |
5 | Ribosome_Homo sapiens_hsa03010 | 2.46476968 |
6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.44216088 |
7 | Lysosome_Homo sapiens_hsa04142 | 2.24383946 |
8 | Base excision repair_Homo sapiens_hsa03410 | 2.23326669 |
9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.03035629 |
10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.94427453 |
11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.94216969 |
12 | Viral myocarditis_Homo sapiens_hsa05416 | 1.90448766 |
13 | Proteasome_Homo sapiens_hsa03050 | 1.71622086 |
14 | Spliceosome_Homo sapiens_hsa03040 | 1.69094679 |
15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.68061679 |
16 | Phagosome_Homo sapiens_hsa04145 | 1.65178861 |
17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.64262564 |
18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.59358917 |
19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.55363782 |
20 | Measles_Homo sapiens_hsa05162 | 1.50411916 |
21 | Malaria_Homo sapiens_hsa05144 | 1.48841145 |
22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.45200838 |
23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.44922994 |
24 | Legionellosis_Homo sapiens_hsa05134 | 1.41348324 |
25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.39242266 |
26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.38724001 |
27 | Asthma_Homo sapiens_hsa05310 | 1.37648394 |
28 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.31626300 |
29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.31625660 |
30 | Homologous recombination_Homo sapiens_hsa03440 | 1.31562210 |
31 | RNA transport_Homo sapiens_hsa03013 | 1.25878600 |
32 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.25171423 |
33 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.25091694 |
34 | Shigellosis_Homo sapiens_hsa05131 | 1.24954931 |
35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.21209579 |
36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.19624309 |
37 | Cell cycle_Homo sapiens_hsa04110 | 1.18988167 |
38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.18025035 |
39 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.17873397 |
40 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.16888895 |
41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.16654792 |
42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.16288016 |
43 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.16016425 |
44 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.15144973 |
45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.14606176 |
46 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.13758347 |
47 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.12709108 |
48 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.10673835 |
49 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.09171037 |
50 | RNA polymerase_Homo sapiens_hsa03020 | 1.08697484 |
51 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.08579997 |
52 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.06525444 |
53 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.04807017 |
54 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.04300083 |
55 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.03614883 |
56 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.02926285 |
57 | Apoptosis_Homo sapiens_hsa04210 | 1.01608430 |
58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.00529537 |
59 | Carbon metabolism_Homo sapiens_hsa01200 | 1.00334225 |
60 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.99862835 |
61 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.98223747 |
62 | Endocytosis_Homo sapiens_hsa04144 | 0.95627203 |
63 | Tuberculosis_Homo sapiens_hsa05152 | 0.95226699 |
64 | Influenza A_Homo sapiens_hsa05164 | 0.94470826 |
65 | Bladder cancer_Homo sapiens_hsa05219 | 0.94385414 |
66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.92701489 |
67 | Parkinsons disease_Homo sapiens_hsa05012 | 0.92642488 |
68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91602910 |
69 | Salmonella infection_Homo sapiens_hsa05132 | 0.91439275 |
70 | Pertussis_Homo sapiens_hsa05133 | 0.90683511 |
71 | RNA degradation_Homo sapiens_hsa03018 | 0.90675624 |
72 | Platelet activation_Homo sapiens_hsa04611 | 0.89563529 |
73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.88606478 |
74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88086672 |
75 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.87778750 |
76 | HTLV-I infection_Homo sapiens_hsa05166 | 0.86156154 |
77 | Hepatitis B_Homo sapiens_hsa05161 | 0.85756781 |
78 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.83300912 |
79 | Prion diseases_Homo sapiens_hsa05020 | 0.83186811 |
80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.82869533 |
81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81680715 |
82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.80391341 |
83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.79521393 |
84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.79494630 |
85 | Allograft rejection_Homo sapiens_hsa05330 | 0.78089896 |
86 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.76916373 |
87 | Hepatitis C_Homo sapiens_hsa05160 | 0.76344143 |
88 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.76198084 |
89 | Amoebiasis_Homo sapiens_hsa05146 | 0.75605089 |
90 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74088440 |
91 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.73207022 |
92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.72310654 |
93 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71363495 |
94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69488575 |
95 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.68538155 |
96 | Sulfur relay system_Homo sapiens_hsa04122 | 0.67004666 |
97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63296332 |
98 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.62332066 |
99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59088060 |
100 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57461276 |
101 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57241587 |
102 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56893770 |
103 | Insulin resistance_Homo sapiens_hsa04931 | 0.56479363 |
104 | Colorectal cancer_Homo sapiens_hsa05210 | 0.56356548 |
105 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.55557823 |
106 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55448122 |
107 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.55447622 |
108 | Thyroid cancer_Homo sapiens_hsa05216 | 0.55340110 |
109 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.55011011 |
110 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.54405235 |
111 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53095293 |
112 | Purine metabolism_Homo sapiens_hsa00230 | 0.52725329 |
113 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52320649 |
114 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52201685 |
115 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.52068376 |
116 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.51300136 |
117 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51227306 |
118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50470960 |
119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.50423041 |
120 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.50225924 |
121 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49725235 |
122 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.49421870 |
123 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.48848899 |
124 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48734626 |
125 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48442346 |
126 | Huntingtons disease_Homo sapiens_hsa05016 | 0.46724152 |
127 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.46624104 |
128 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.46232606 |
129 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.39588050 |
130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38905081 |
131 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.38819123 |
132 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37152827 |
133 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.35846258 |
134 | Focal adhesion_Homo sapiens_hsa04510 | 0.35396076 |